Dupixent Lawsuits Now Under Investigation In this issue, we have information about Dupixent, an injectable drug used to treat eczema, asthma, and more, and how it may be linked to a very specific form of T-cell lymphoma. Patients who were diagnosed with this type of cancer may now have legal recourse. More on that below. From there, investigations are looking into a fitness tracker that may be illegally sharing users’ information and whether a senior living community is underpaying its workers. We’ll round things out with an ongoing lawsuit filed over potentially defective sneakers, as well as the latest in class action settlements. Keep reading for the details. - Ty Armstrong, Writer/Community Manager |
| Attorneys working with ClassAction.org are looking to file lawsuits on behalf of patients who used Dupixent and were diagnosed with cutaneous T-cell lymphoma. Allegations have surfaced that the drug’s makers knew about this risk but failed to properly warn patients and doctors. If you or a family member was diagnosed with this form of non-Hodgkin lymphoma, which primarily affects the skin, learn more about filing a lawsuit and what you could be owed. |
Is Whoop Sharing Your Personal and Health Data? Attorneys have reason to believe that a web tracker on Whoop’s platform may be collecting personal data and sharing it with third-party advertisers without permission. This information could potentially include a user’s video-viewing history and personally identifying details, as well as data related to gender, height and weight. More information on Whoop, including how you can join others taking action, can be found here. |
| New Data Breach Investigations | | | Got a data breach
notice? Don’t throw it out – and check out our full list of ongoing investigations here. You may be able to help get a class action lawsuit started. | |
| | ~ In Case You Missed It ~ Nest Support Discontinued? Join Others Taking Action Google has announced that it will no longer support older Nest Learning Thermostats—specifically, first-generation (2011) and second-generation (2012) models—starting on October 25, 2025. Attorneys working with ClassAction.org believe Google may have violated customers’ rights by doing so and are now gathering affected consumers to take legal action through mass arbitration. This page has all the details, including how to see if you qualify and what you could be owed. |
Case Updates  Our settlements page is always being updated. Have you checked to see if you're covered by any open settlements? You can also check out the latest settlements as they happen by following us on Twitter. |
| Latest Settlements - TreeHouse Foods – Frozen Breakfast Food Recall
You may be included in this settlement if you, between October 18, 2024 and September 2, 2025, bought certain frozen breakfast food products involved in a voluntary recall over potential listeria contamination. - YouTube – Child Privacy
You may be able to claim a piece of this settlement if you (or your child) were under 13 years old and watched content allegedly directed to children on YouTube between July 1, 2013 and April 1, 2020. - Pacific Guardian Life Insurance – Data Breach
This settlement covers those who were notified that their private information was potentially compromised in a Pacific Guardian Life Insurance data breach that took place in August 2023. | | |
To view a complete list of settlements and to find out how you can file a claim, click here. |
|
|---|
| | ~ In Other News ~ | If you worked for Benchmark Senior Living, which operates a network of senior living communities across the Northeast, attorneys want to speak with you. They have reason to believe that Benchmark may be failing to factor in extra shift bonuses, shift differentials and other types of non-discretionary pay when determining employees’ overtime rates, resulting in underpayment. Learn more about what you can do on this page. |
| A proposed class action lawsuit alleges that On sneakers designed with CloudTec cushioned support technology suffer from a defect that produces a loud, bothersome squeak with each step. As the lawsuit tells it, On has drawn the ire of consumers after refusing to remedy the defect, which, though seemingly inconsequential, has left consumers with “no relief after buying almost $200 shoes.” Read up on the case here. |
~ Forward to a friend ~
Know someone who might be interested in our newsletter? Why not forward this email to them?
|
|---|
|
|
Please do not reply to this message.
Replies to this message are routed to an unmonitored mailbox. Thank you. |
